What's New

Bug Fixes, Improved performance of the application

App Description

An app for the TAK-660-403 Protocol. Evaluation of long-term safety of ADYNOVI / ADYNOVATE(Antihaemophilic Factor [Recombinant] PEGylated, rurioctocog alfa pegol) in patients with haemophilia A – An ADYNOVI / ADYNOVATE Post-Authorisation Safety Study (PASS)

iPhone Screenshots

(click to enlarge)

TAK-660-403 screenshot 1 TAK-660-403 screenshot 2 TAK-660-403 screenshot 3 TAK-660-403 screenshot 4

iPad Screenshots

(click to enlarge)

TAK-660-403 screenshot 5 TAK-660-403 screenshot 6 TAK-660-403 screenshot 7 TAK-660-403 screenshot 8

App Changes

  • July 15, 2020 Initial release
  • September 15, 2023 New version 1.1